My watch list
my.bionity.com  
Login  

Dementia

Companies Dementia

Asceneuron SA, Switzerland

Asceneuron was founded in 2012 through a spin-off of Merck Serono’s Alzheimer’s drug discovery portfolio and research group in Switzerland. We are a privately held company financed by a strong syndicate of investors consisting of Sofinnova Partners, SR One, Johnson & Johnson Innovation – JJDC, Inc. more

Predemtec GmbH, Germany

We are a company focused on the research, development and manufacture of innovative diagnostic tests for use in the detection of dementia-related risk factors. Our goal has been to make the early and reliable diagnosis of various dementia-related illnesses a reality through the use of our innovative more

Alzheon, Inc., USA

We are a clinical-stage biopharmaceutical company with a Phase 3-ready program in Alzheimer’s disease and a discovery platform of small molecules for the treatment of neurodegenerative disorders. We are developing these disease modifying treatments by leveraging our expertise in inhibiting protein m more

All companies on dementia

News Dementia

All news on dementia

Videos Dementia

Chaperones - folding helpers in the cell

Nothing works without the correct form: For most proteins, there are millions of ways in which these molecules, composed of long chains of amino acids, can be folded - but only one way is the right one. Researchers in the department "Cellular Biochemistry" at the Max Planck Institute for Biochem ... more

White papers Dementia

Events Dementia

Webinar
On-Demand

Characterization of AD Animal Models: Building In Vivo Tools to Assess Next-Generation AD Therapeutics

                        Preclinical development of drug candidates for Alzheimer’s disease (AD) takes multiple different paths; animal models are indispensable tools to support diverse preclinical drug development programs. Charles River performs in-house evaluations employing several mouse models

Publications Dementia

All publications on dementia

Market studies Dementia

  • Lewy body Dementia – Pipeline Review, H2 2012

    Introduction Global Markets Direct’s, 'Lewy body Dementia - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Lewy body Dementia, complete with latest updates, and special features on late-s more

  • AIDS Associated Dementia – Pipeline Review, H2 2012

    Introduction Global Markets Direct’s, 'AIDS Associated Dementia - Pipeline Review, H2 2012', provides an overview of the AIDS Associated Dementia therapeutic pipeline. This report provides information on the therapeutic development for AIDS Associated Dementia, complete with latest updates, and sp more

  • AIDS Associated Dementia – Pipeline Review, H1 2012

    Introduction Global Markets Direct’s, 'AIDS Associated Dementia - Pipeline Review, H1 2012', provides an overview of the AIDS Associated Dementia therapeutic pipeline. This report provides information on the therapeutic development for AIDS Associated Dementia, complete with latest updates, and spe more

All market studies on dementia
Definition

Dementia

Dementia Dementia (from Latin de- "apart, away" + mens (genitive mentis) "mind") is the progressive decline in cognitive function due to damage or disease in the brain beyond what might be expected from normal aging . Although dementia is ... more

Watchlist

This is where you can add this topic to your personal favourites

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE